PLC may may act as a nutritional agent relieving clinical symptoms of cardiovascular conditions such as peripheral arterial disease, cardiomyopathy, angina, peripherial arterial disease, congestive heart failure and other heart problems due to ageing. Studies suggest that PLC is much more effective than L-Carnitine in repairing arterial endothelial cells. It is the arterial endothelial cell damage that causes LDL and triglyceride deposits, clotting and the site for fibrinigen plaque.
The statin manufacturers are conducting studies to determine if statins can have the same overall effect as PLC. |
